United States
Print page content Print
Increase text size Decrease text size
Text Size

A Combination Vaccine Built from the Ground Up

  • True combination vaccine, not a mix of 2 existing products
  • Aspects of human vaccine technology applied to the
    manufacturing process
  • Manufacturing process helps remove extraneous proteins that can
    affect efficacy and safety

- PCV2 antigen is concentrated and diafiltrated
- M. hyo antigen is filtered and treated with Protein A to help reduce
  anti-PCV2 and other antibodies resulting in better compatibility
  with PCV2 antigen

  • Non-virucidal MetaStim® adjuvant helps induce an effective immune response